FDA Draft Guidance Fails To Deliver On AER Label Addresses – CSPI
This article was originally published in The Tan Sheet
Executive Summary
The Center for Science in the Public Interest urges FDA to require complete addresses on OTC and supplement product labels for compliance with the adverse event reporting law that goes into effect Dec. 22
You may also be interested in...
SBA Advocacy Office Joins Industry In Opposing AER Labeling Guidance
FDA should "better analyze the possible effects" its adverse event reporting draft guidance will have on the dietary supplement industry, according to the Small Business Administration's independent Office of Advocacy
SBA Advocacy Office Joins Industry In Opposing AER Labeling Guidance
FDA should "better analyze the possible effects" its adverse event reporting draft guidance will have on the dietary supplement industry, according to the Small Business Administration's independent Office of Advocacy
SBA Advocacy Office Joins Industry In Opposing AER Labeling Guidance
FDA should "better analyze the possible effects" its adverse event reporting draft guidance will have on the dietary supplement industry, according to the Small Business Administration's independent Office of Advocacy